SCHEMBL414684

SCHEMBL414684

C[C@H](Nc1cccc2cc3ccccc3cc12)C(=O)O.C[C@H](Nc1cccc2cc3ccccc3cc12)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
KDM4E B2RXH2 4/20 0.46
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 2/20 0.46
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
TNNI3 P19429 1/20 0.40
TNNT2 P45379 1/20 0.40
TNNC1 P63316 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 1/20 0.40
CCKAR P32238 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL837924 1.00 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL29414377 1.00 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL1115756 1.00 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL277555 0.96 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL29367675 0.85 CA12 (0.54) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL409050 0.85 CA12 (0.54) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL29478385 0.85 CA12 (0.54) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL42287 0.85 CA12 (0.54) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL42286 0.85 CA12 (0.54) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL298855 0.85 CA12 (0.54) ALDH1A1MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2021-02-04 US claimed
US-20170209845-A1 FORMATION OF ORGANIC NANOSTRUCTURE ARRAY RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2017-07-27 US claimed
EP-2089418-B1 FORMATION OF ORGANIC NANOSTRUCTURE ARRAY UNIV RAMOT (IL) 2016-11-09 EP claimed
US-9074095-B2 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2015-07-07 US claimed
US-20130079421-A1 MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2013-03-28 US claimed
US-20090175785-A1 Self-Assembled Fmoc-Ff Hydrogels RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2009-07-09 US claimed
EP-1973928-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS Ramot at Tel-Aviv University Ltd. (IL) 2008-10-01 EP claimed
WO-2007043048-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-04-19 WO claimed
US-20240167062-A1 HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2024-05-23 US disclosed
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2021-02-04 US disclosed
US-10245351-B2 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2019-04-02 US disclosed
US-10115584-B2 Composition and method for forming a dielectric layer RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2018-10-30 US disclosed
US-10086354-B2 Formation of organic nanostructure array RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2018-10-02 US disclosed
US-10004828-B2 Self-assembled Fmoc-ff hydrogels Romat at Tel-Aviv University Ltd. (IL) 2018-06-26 US disclosed
US-20090175785-A1 Self-Assembled Fmoc-Ff Hydrogels RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2009-07-09 US disclosed
WO-2009034566-A1 VAPOR DEPOSITION OF BIOMOLECULES RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2009-03-19 WO disclosed
EP-1973928-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS Ramot at Tel-Aviv University Ltd. (IL) 2008-10-01 EP disclosed
WO-2008068752-A2 FORMATION OF ORGANIC NANOSTRUCTURE ARRAY RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2008-06-12 WO disclosed
US-20070138007-A1 Peptide nanostructure-coated electrodes RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-06-21 US disclosed
WO-2007043048-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240167062-A1 HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION HIF1A, HAO2, EGLN2 ALDH1A1 1168/4885MEN1 4807/4885KMT2A 2579/4885
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION VIP, NPPA, IAPP ALDH1A1 4708/4885MEN1 3992/4885KMT2A 4372/4885
US-10086354-B2 Formation of organic nanostructure array NCL, SOD1, NES ALDH1A1 630/4885MEN1 4375/4885KMT2A 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.